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A B S T R A C T
Dysplastic nevus is an acquired or hereditary nevus that clinically seems atypical and pathohistologically dysplastic.
The term of dysplastic nevus has chaged through history and even until now the dermatologists and pathologists have
not found the same conclusion for name and definition of dysplastic nevus. Epidemiology of dysplastic nevus is different
depending on geographic lattitude, being three times higher in Australia than in Great Britain. Genetic factors play a
role in etiology of dysplastic nevus but are still not well defined. UV radiation is indisputable main etiological factor in
developing dysplastic nevus. Many studies confirm that children who have been using sun protection creams with SPF
have less dysplastic nevi than those who did not. Nevus with geographic shape and muddy borders, dominately macular,
red to brown colored and has 5 mm or more in diameter is clinically dysplastic nevus. ABCDE rules count for dysplastic
nevus as well as for melanoma but prefferable diagnostic criteria for dysplastic nevus would be »ugly duckling sign«.
Pathohistologic analysis is the key in confirming the diagnosis of dysplastic nevus. Great experience and knowledge in
dermatopathology field is essential for pathologists to make a distinction between dysplastic nevus and melanoma in
situ. Likewise great experience in dermatooncology field is essential in differentiating dysplastic nevus from other nevi.
Surgical excision is the only therapy that should be done for dysplatic nevus. Regular follow up is highly recommended
for patients with dysplatic nevus and syndroma naevi dysplastici. Education about sun protection measures and self-ex-
amination techniques is essential for all patients with dysplastic nevi and their family.
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Introduction
Dysplastic nevus is an acquired or hereditary nevus
that clinically seems atypical and pathohistologically dys-
plastic. Many debates and controversies have been car-
ried out until today about dysplastic nevus. Does it exist
or not? Most melanoma occur »de novo« but 20–30% of
melanoma arises from pigemnted precursor, dysplastic
nevus. Chen said that it is not important what one ob-
serves but what one believes1. There are two theories in
which you can believe. Multistep tumorogenesis theory,
which begins with normal melanocytes to hyperplasia to
nevus than dysplastic nevus and finally melanoma. It is
applicable for many carcinomas like colorectal carcinoma.
Other theory describes dysplastic nevus as intermediate
lesion that does not exist because neoplasms are altera-
tions in DNA which are nonsequential and stochastic.
Ackerman said: »In the realm of melanocytic neoplasms,
there are only four possible answers: nevus, melanoma,
melanoma in association with a nevus, and I don't know«2.
Nomenclature, epidemiology and etiology
The term of dysplastic nevus has changed through
history and even until now the dermatologists and pa-
thologists have not found the same conclusion for name
and definition of dysplastic nevus. In 1800 Norris re-
ported appearance of great number of nevi in members of
two families in which two members died frommelanoma.
In 1974 Munro described clinical and microscopic fea-
tures of atypical nevi in families with reported melanoma
occurence. The term B-K moles appears in 1978 when
Clark recognized the first two families with atypical nevi
whose surnames began with B and K3. The term familial
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atypical multiple mole and melanoma syndrome was pro-
posed by Fussaro in 1983. In 1985 Elder explaned the
theory of »nevus-melanoma« for sporadic dysplastic nevi
as precursors of melanoma. Today most used nomencla-
ture for dysplastic nevus is Clark’s nevus, atypical mole
and nevus with architectural disorder (with varying de-
grees of melanocytic atypia).
Atypical mole syndrome (AMS) had different criteria
through history. Newton et al. made criteria in 1993. In
1990s Classical atypical mole syndrome included having
more than 100 nevi, one nevus 8 mm in diameter or more
and at least one lesion with atypical features. In 1992
National Institute of Health (NIH) brought Consensus of
AMS with characteristics of occurence of melanoma in
one or more first or second degree relatives, having large
number of melanocytic nevi, more than 50, some being
atypical and variable in size and having melanocytic nevi
that present certain histological features4.
Dysplastic nevus is relatively common in general pop-
ulation. Epidemiology of dysplastic nevus is different de-
pending on geographic lattitude, being 3 times higher in
Australia than in Great Britain. Some authors reported
prevalence ranging from 2–53% depending on the diag-
nostic criteria. The prevalence is much higher in patients
with melanoma being 34–59%. Epidemiology of AMS de-
pends on diagnostic criteria. NIH estimated that in 1985
about 32,000 individuals had AMS and familiar mela-
noma in the Unites States of America and 3 milion peo-
ple had sporadic AMS4.
The etiology of dysplastic nevus is complex. It is inter-
action of multiple genes and enviromental factors. Ge-
netic factors are still not well defined. There are no cer-
tain genes or molecular mechanism which is key in
development of dysplastic nevus. Loss of heterozigocity
on chromosome 9p21 gene p16 has been detected in mel-
anoma, dysplastic nevus and benign nevus5. Homozigotic
deletion of p16 was found in melanoma and dysplastic
nevus5. Mutation of genomic locus CKDN2A on chromo-
some 9p21 was found in melanoma but not in dysplastic
nevus, so in families with mutation of CKDN2A nevus
dysplasticus is independent risk factor for development
of melanoma5. Other mutations of BRAF, PTEN, CDK4
genes were not found in dysplastic nevi but mutation of
NRAS gene was confirmed in dysplastic nevus5. UV radi-
ation is indisputable main etiological factor in developing
dysplastic nevus. Intermitent sun exposure and sun-
burns in childhood are related with development of mela-
noma as well as dysplastic nevi. Many studies confirmed
that children who have been using sun protection creams
with Sun Protection Factor (SPF) have less dysplastic
naevi than those who did not5. One study reported higher
prevalence of dysplastic nevi in Australian than United
Kingdom, but the incidence of dysplastic nevi on but-
tocks were the same5.
Clinical Findings
Clinically a dysplastic nevus is most often nevus with
geographic, poligonal or rhomboid shape and muddy bor-
ders, dominately macular, red to brown colored and has
5 mm or more in diameter. »The fried egg« sign is de-
scribed for dysplastic nevus with macular and central
papular component. ABCDE rules count for dysplastic ne-
vus as well as for melanoma being A-asymmetry, B-irregu-
lar borders, C-varied colour, D-diameter more than 6 mm,
but prefferable diagnostic criteria for dysplastic nevus
would be »ugly duckling sign«. It is a nevus which »pops
in« from other nevi on the patient’s skin. Different clinical
appearance of dysplastic nevi is possible in one patient
and in one family. Patient usually during examination
explanes: »My father and grandfather are full of moles
like me.« When asking about sun behavior patterns pa-
tient says: »I had many sunburns in childhood. Before no-
body took care about sun protection behavior.« Other in-
formation like articifial sunbathing, time of day exposed
to sun, outdoor hobbies and sun protective behavior can
contribute in decision about excision and follow up of the
patient. Topography of dysplastic nevi can be any. The
most often localisation is trunk, especially the torso. It is
important to serach for dysplastic nevi on special sites
like acral parts, scalp, foldings and buttocks. It is requi-
red to search for other solar damages on patient’s skin
like solar/senil lentigines, precanceroses or skin cancer.
Dysplastic nevi are dynamic lesions, which mostly oc-
cur in puberty and may become more atypical in clinical
appearance or can regress over time but majority of
dysplastic nevi remain stable. Erythema in dysplastic ne-
vus and regression of lesion are possible signs of develop-
ment of melanoma.
Pathohistological anaylsis and differential
diagnosis
Pathohistological analysis is the key in confirming the
diagnosis of dysplastic nevus. NIH and World Health Or-
ganisation made consensus on the major mandatory patho-
histological criteria and minor criteria for the diagnosis
of dysplastic nevus6. Major criteria include lentiginous or
contiginous melanocytic hyperplasia and focal melano-
cytic atypia. For the diagnosis of dysplastic nevus there
should be at least two minor criteria: »shoulder phenom-
enon«, fusion of epithelial cones, subepidermal concen-
tric lamellar fibrosis and superficial perivascular lym-
phocitic inflammatory infiltrate. Great experience and
knowledge in dermatopathology field is essential for pa-
thologists to make a distinction between dysplastic nevus
and melanoma in situ. Today melanoma is the most fre-
quent cause of medicolegal lawsuit for pathologist7. There-
fore overdiagnosing melanoma is more often than under-
estimation but has great consequences for the patients.
Differental diagnosis is wide ranging from seborrhoic
keratosis, dermatofibroma, traumatised mole, lentigo so-
laris, Meyerson nevus, nevus Spillus, blue nevus, pigment-
ed actinic keratoses, basal cell carcinoma, squamous cell
carcinoma and melanoma8. Likewise great experience in
dermatooncology field is essential in differentiating dys-
plastic nevus from other nevi. Today non-invasive method
dermatoscopy is very useful tool in every day dermato-
oncology practice. Kittler et al showed 49% improvment
in diagnostic accuracy in meta-analysis of 27 studies9. It
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is important to emphasise that great clinical experience
is important in differentiating which lesions are »at the
edge« of clinical diagnosis and where our eye is insuffi-
cient so dermatoscopy can be relevant.
Conclusion
Surgical excision is the only therapy that should be
done for dysplatic nevus. Prophylactic excisions of all
clinically dysplastic nevi is not the solution. As it is
known that 20–30% of all melanoma arise from nevus so
prophylactic excisions would not prevent melanoma de-
velopment. There are many patients who seek private
physicians for multiple excisions of nevi which can give a
patient a false sence of security. There is still increased
risk for development of melanoma.
Regular follow up is highly recommended for patients
with dysplatic nevus and AMS. It should be every 3–12
months depending on patient’s risk to development of
melanoma. Dermatoscopy increases the diagnostic accu-
racy and if possible it should be done on every patient’s
follow up. Education about sun protection measures and
self-examination techniques is essential for all patients
with dysplastic nevi and their family. Sun protection
measures are not just using sun creams with SPF but
also seeking shade, wearing protective clothes and sun-
glasses10–12. Use of sun creams with SPF reduces the inci-
dence of precanceroses and melanocytic nevi. Patients
should not apply sun creams with SPF to prolong being
on the sun. Usually patients are dissapointed with not
getting tanned but new life behavior and attitudes must
be adopted. Giving patient few minutes more during ex-
amination and explaning him/her about UV light as
»nevogenic« factor and protection measures can contrib-
ute a lot to increase awareness and changes in sun be-
havior and attitudes.
R E F E R E N C E S
1. CHEN S, Am J Dermatopathol, 32 (2010) 858. — 2. ACKERMAN
AB, CAVEGN BM, ROBINSONMJ, ABAD-CASINTHAHANMFA, Acker-
man’s Resolving Quandaries in Dermatology, Pathology and Dermatopatho-
logy (Philadelpha, PA: Williams & Wilkins, 1995). — 3. GARGANTINI
REEZE G, LEON A, DUPRAT J, An Brass Dermatol, 85 (2010) 863. — 4.
HYPOLITO SILVA J, BC DE SA, RIBEIRO DE AVILA AL, LANDMAN
G, DUPRAT NETO JP, Clinics, 66 (2011) 493. — 5. TUCKER MA, Atypi-
cal Melanocytic Nevi. In: WOLFF K; GOLDSMITH LA, KATZ SI, GIL-
CHREST BA, PALLER AS, LEFFELL DJ (Eds) Fitzpatrick’s Dermatology
in General Medicine (McGraw Hill, 2008). — 6. LANDMANG, Acta oncol
Bras, 23 (2003) 514. — 7. MASSI G, Wirchows Arch, 451 (2007) 623. — 8.
BULJANM, SITUMM, TOMAS D, CAVKA V, PODUJE S, GASPAROV S,
Coll Antropol, 34 (2010) 307. — 9. KITTLER H, PEHAMBERGER H,
WOLFF K, BINDER M, J Am Acad Dermatol, 43 (2000) 467. — 10. MA-
SNEC IS, KOTRULJA L, SITUMM, PODUJE S, Coll Antropol, 34 (2010)
257. — 11. TARBUKA, GRANCARI] AM, SITUMM,MARTINISM, Coll
Antropol, 34 (2010) 179. — 12. SITUM M, VURNEK ZIVKOVI] M,
DEDIOL I, ZELJKO PENAVI] J, SIMI] D, Coll Antropol, 34 (2010) 141.
I. Dediol
Department of Dermatovenerology, »Sestre milosrdnice« University Hospital Center, Vinogradska cesta 29,
10000 Zagreb, Croatia
e-mail: ivablajic@hotmail.com
DISPLASTI^NI NEVUS – RIZI^NI ^IMBENIK ILI MASKA MELANOMA
S A @ E T A K
Displasti~ni nevus je ste~eni ili hereditarni nevus koji je u klini~koj slici atipi~an te u patohistolo{koj slici displasti~an.
Naziv displasti~nog nevusa se mijenjao kroz povijest pa ~ak i do danas dermatolozi i patolozi nisu donijeli zajedni~ku
odluku oko naziva i definicije displasti~nog nevusa. Epidemiologija displasti~nog nevusa ovisi o geografskoj {irini te je
tako displasti~ni nevs 3 pura ~e{}i u stanovnika Australije nego Ujedinjenog Kraljevstva. U etiologiji displasti~nog nevusa
geni imaju ulogu no jo{ nije razija{njeno kakvu. Glavni vanjski etiolo{ki ~imbenik, koji dovodi do nastanka displasti~nog
nevus,a je UV zra~enje. Brojne studije su pokazale da djeca koja su u mladosti koristila kreme sa za{titnim faktorom
imaju manje displasti~nih nevusa. Displasti~ni nevus klini~ki ima geografski oblik s mutnim rubovima, dominantno ma-
kularna lezija, od crvene do sme|e boje i 5 mm ili ve}i u promjeru. ABCDE pravila su korisna u dijagnostici displasti~nih
nevusa iako se danas vi{e koristi tzv »znak ru`nog pa~eta«. Dijagnoza se potvr|uje patohistolo{kom analizom. Potrebno je
veliko iskustvo i znanje iz podru~ja dermatopatologije kako bi se napravila granica izme|u displasti~nog nevus ai mela-
noma in situ. Jedini terapijski izbor je kirur{ka ekscizija suspektnog displasti~nog nevusa. Jako je bitno da bolesnici s
displasti~nim nevusima i sindromom displasti~nih nevusa redovito dolaze na kontrolne preglede. Tako|er je bitno bole-
snicima pru`iti edukaciju o mjerama za{tite na suncu i samopregledima ko`e.
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